Cephalosporins - Orals
| Product |
Pharmacopeia |
DMF Availability |
COS |
| Cefalexin |
EP / BP / USP / JP |
√ |
√ |
| Cefadroxil |
EP / BP / USP / JP |
√ |
√ |
| Cefixime |
EP / BP / USP |
√ |
√ |
| Cefradine |
USP / EP / BP |
√ |
√ |
| Cefuroxime Axetil (Amorphous) |
USP / EP / BP / JP |
√ |
√ |
| Cefuroxime Axetil (Crystalline) |
USP |
√ |
- |
| Cefprozil |
USP |
√ |
- |
| Cefditoren Pivoxil (Amorphous) |
In-house |
√ |
- |
| Cefditoren Pivoxil (Crystalline) |
USP / JP |
√ |
- |
| Cefdinir |
USP / JP |
√ |
- |
| Cefpodoxime Proxetil |
USP / EP / JP |
√ |
- |
| Ceftibuten |
In-house |
√ |
- |
| Cefcapene Pivoxil Hydrochloride |
JP |
TIP |
- |
| Ceftamet Pivoxil |
JP |
TIP |
- |
Disclaimer
Product exploitation, including development, sales and offer for sale are performed where permissible by patent law. This presentation is not and should not constitute as an offer for sales in territories where it is not permitted by law.